|
|
September 26, 2011 - Collegium Pharmaceutical Inc. Announces Successful Type A Meeting with FDA for Tamper-Resistant, Extended Release Opioid
|
|
|
February 22, 2012 - Collegium Pharmaceutical Announces Series B Financing and Advancement of Development Program for its DETERx® Tamper-Resistant, Extended-Release Opioid
|
|
|
December 1, 2010 – Collegium Pharmaceutical Announces the Spin-out of Onset Therapeutics and the Launch of PreCision Dermatology Inc
|
|
|
August 18, 2010 – Collegium Pharmaceutical Inc. Announces Second U.S. Patent Issued Covering DETERx™ Technology
|
|
|
June 10, 2010 – Collegium Pharmaceutical Inc. Receives FDA Fast Track Designation for Tamper Resistant, Chronic Pain Product, COL-172
|
|
|
May 20, 2010 – Collegium Pharmaceutical Inc. Announces Notice of Allowance for Second DETERx™ Technology Patent
|
|
|
March 31, 2010 – Collegium Pharmaceutical Receives Notice of Allowance for US Patent Covering Novel Once-a-Day Formulation of Milnacipran
|
|
|
March 26, 2010 – Collegium Pharmaceutical Inc. Announces Filing of IND for Second Chronic Pain Product Using DETERx™ Tamper-Resistant, Extended Release Technology
|
|
|
February 3, 2010 – Collegium Pharmaceutical Inc. Presents Scientific Poster for DETERx™ Tamper-Resistant, Extended Release Technology at American Academy of Pain Medicine’s 26th Annual Meeting
|
